Latest Industry Projects

All producers and purchasers wish to engage with the continuous process of design and development in the Pharmaceutical industry. In order to fulfill this expectation, our portal offers a meticulous compilation of on-going as well as potential projects.

Takeda Pharmaceutical Company Limited Invests €40 Million for New Production Facility in Dublin

Introduction: Takeda Pharmaceutical Company Limited announced plans to invest €40m in a new facility at their Grange Castle site in Dublin. Features: This Investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone high containment production facility dedicated to manufacturing its oncology…

BD Invests $100 Million to Expand Insulin Syringe Manufacturing at Nebraska Plant

Introduction: BD (Becton, Dickinson and Company), a leading global medical technology company announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its insulin syringe manufacturing operations. Features: The investment will be used for new technology and manufacturing equipment to expand capacity for BD insulin…

EMD Serono to Invest $12 Million to Expand Biopharmaceutical R&D Facility in Billerica, Massachusetts

Introduction: EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in North America, today announced a $12 million investment for the expansion of its R&D facility in Billerica, Massachusetts. Features: The new building will span more than 30,000 square feet and accommodate approximately 120 new and current employees whose…

Merck Invests €50 Million in Pharmaceutical Packaging Building in Darmstadt, Germany

Introduction: Merck, a leading science and technology company, announced an investment of more than €50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany. Features: With its state-of-the art, flexible and modern technology, this new center of excellence will enable the packaging of more than…

Piramal Pharma Solutions to invest $25 Million to expand its Capacity for Sterile Manufacturing in Lexington

Introduction: Piramal Pharma Solutions, a provider of sterile drug product development and manufacturing services, has announced plans for a $25 million expansion of its facilities in Lexington, Kentucky. Features: Piramal Pharma Solutions’ plan focuses on expanding the Lexington site capabilities and capacity for commercial aseptic manufacturing. This will be done…

GSK to Invest £275 Million in UK Manufacturing Network

Introduction: GSK announced £275 million of new investments at three of its manufacturing sites in the UK to boost production and support delivery of its latest innovative respiratory and large molecule biological medicines. Features: The vast majority of these products will be for export to global markets. GSK has a…

Novo Nordisk invests DKK 400 Million for expansion of production plant in Kalundborg, Denmark

Introduction: Novo Nordisk is investing 400 million Danish kroner in a 500 m2 extension of the world's largest insulin production plant in Kalundborg. Features: The expansion of production plant highlights our ambition to continue strengthening our presence in Kalundborg. The new facilities will give us greater flexibility and enable the…

Fermion Invests EUR 30 Million for API Manufacturing Facility Expansion in Hanko, Finland

Introduction: Fermion announced plans for for API Manufacturing Facility Expansion in Hanko, Finland with an investment of EUR 30 million. Features: The expansion lifts Fermion to a new level in the global arena of API and especially HAPI manufacturing, improving Fermion’s capability to meet increasing demand. Fermion will continue to…

Novo Nordisk to Invest €100 Million in Production Plants in Chartres, France

Introduction: Novo Nordisk announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. Features: The expansions will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines. The new facilities will be built on Novo Nordisk's existing 31,000…

Vetter to Build €70 Million Production Facility at Ravensburg, Germany

Introduction: Vetter, a leading global contract development and manufacturing organization (CDMO) for the development, commercial manufacturing and final packaging of aseptically prefilled drug-delivery systems announced the construction of a new building at a ground breaking ceremony held at its Ravensburg Schuetzenstrasse site. Features: The seven story building will cover a…